Skip to main content
. Author manuscript; available in PMC: 2020 Jun 6.
Published in final edited form as: AIDS Behav. 2020 Jun;24(6):1893–1902. doi: 10.1007/s10461-019-02759-3

Table 3.

Psychosocial outcomes at baseline, post-treatment, and follow-up assessments

Variable Baseline assessment Post-treatment assessment Follow-up assessment
PATCH (n = 17) SRSP (n = 17) PATCH (n = 15) SRSP (n = 14) ES PATCH (n = 14) SRSP (n = 14) ES
M (SD) M (SD) M (SD) M (SD) M (SD)
BSI global severity 41.4 (10.1) 46.2 (10.6) 37.6 (8.0) 50.3 (7.4)*** − 0.55 38.22 (8.4) 43.5 (10.2) − 0.03
BSI positive symptoms 43.4 (11.5) 47.5 (13.7) 39.3 (9.3) 51.4 (11.3) − 0.47 39.8 (8.4) 46.6 (10.6) − 0.18
BSI distress 40.8 (9.3) 46.3 (9.4) 39.5 (9.7) 50.9 (10.1) − 0.35 42.2 (7.3) 46.5 (11.3) 0.14
SF-12 physical composite 43.9 (10.5) 43.5 (7.9) 42.9 (6.9) 44.0 (9.8) − 0.24 43.3 (11.8) 46.6 (6.8) − 0.44
SF-12 mental composite 41.9 (12.7) 44.2 (13.3) 53.5 (12.0) 43.2 (13.5)*** 0.92 52.8 (10.8) 46.9 (9.6)*** 0.65
Alcohol use 1.2 (2.5) 5.6 (8.9) 0.3 (0.7) 8.4 (12.0)*** − 0.42 0.3 (0.8) 1.6 (3.6) 0.46
Drug use 3.6 (9.9) 0.1 (0.2) 1.5 (4.1) 0.4 (1.2) − 0.36 0.6 (1.2) 0.4 (0.9) − 0.47
COPE—Positive 13.5 (2.2) 12.4 (2.1) 11.5 (3.2) 12.3 (1.5) − 0.78 11.9 (2.4) 11.9 (2.9) − 0.43
COPE—Denial 9.2 (3.1) 9.2 (2.8) 8.9 (2.7) 9.4 (3.0) − 0.14 8.6 (3.6) 9.0 (2.4) − 0.09
COPE—Religious 10.8 (2.1) 10.9 (1.9) 10.7 (1.9) 11.9 (2.0) − 0.49 10.6 (1.9) 10.6 (2.3) 0.17
COPE—Emotional 6.4 (3.0) 6.9 (2.7) 5.5 (1.8) 8.8 (3.6)*** − 0.77 6.0 (2.3) 6.0 (2.1) 0.23
COPE—Acceptance 13.1 (2.0) 12.7 (2.6) 13.6 (2.0) 12.6 (2.6) 0.30 12.9 (2.6) 12.2 (2.2) 0.18

Effect size (ES) calculated as group-by-time interaction divided by raw standard deviation at baseline

***

Significant group × time interaction indicating differences in score changes from baseline to indicated timepoint p < 0.05